标题
Mechanisms of bone destruction in multiple myeloma
作者
关键词
-
出版物
EUROPEAN JOURNAL OF CANCER CARE
Volume 26, Issue 6, Pages e12761
出版商
Wiley
发表日期
2017-09-21
DOI
10.1111/ecc.12761
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth
- (2017) J Delgado-Calle et al. LEUKEMIA
- EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma–Induced Epigenetic Suppression of Osteoblast Differentiation
- (2017) Juraj Adamik et al. MOLECULAR CANCER RESEARCH
- Inhibition of Transforming Growth Factor-β Activation Diminishes Tumor Progression and Osteolytic Bone Disease in Mouse Models of Multiple Myeloma
- (2016) Ailing Lu et al. AMERICAN JOURNAL OF PATHOLOGY
- The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors
- (2015) Denise Toscani et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events
- (2014) Swaminathan P. Iyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sotatercept in patients with osteolytic lesions of multiple myeloma
- (2014) Kudrat M. Abdulkadyrov et al. BRITISH JOURNAL OF HAEMATOLOGY
- Oncogenic roles of EMT-inducing transcription factors
- (2014) Alain Puisieux et al. NATURE CELL BIOLOGY
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of bone disease in multiple myeloma
- (2014) Evangelos Terpos et al. Expert Review of Hematology
- Apoptotic Osteocytes and the Control of Targeted Bone Resorption
- (2014) Lilian I. Plotkin Current Osteoporosis Reports
- Osteoblastic Wnts differentially regulate bone remodeling and the maintenance of bone marrow mesenchymal stem cells
- (2013) Yong Wan et al. BONE
- Osteocyte-Driven Bone Remodeling
- (2013) Teresita Bellido CALCIFIED TISSUE INTERNATIONAL
- The effects of bortezomib on bone disease in patients with multiple myeloma
- (2013) Mohamad Mohty et al. CANCER
- Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin
- (2013) Joachim Albers et al. JOURNAL OF CELL BIOLOGY
- Down-Regulation of Canonical and Up-Regulation of Non-Canonical Wnt Signalling in the Carcinogenic Process of Squamous Cell Lung Carcinoma
- (2013) Domokos Bartis et al. PLoS One
- Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy
- (2012) E. Terpos et al. ANNALS OF ONCOLOGY
- Metastatic myeloma?
- (2012) K. Shain BLOOD
- Developmental Stage and Time Dictate the Fate of Wnt/β-Catenin-Responsive Stem Cells in the Mammary Gland
- (2012) Renée van Amerongen et al. Cell Stem Cell
- Osteocyte RANKL: New insights into the control of bone remodeling
- (2012) Jinhu Xiong et al. JOURNAL OF BONE AND MINERAL RESEARCH
- VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology
- (2012) Richard M Taylor et al. LABORATORY INVESTIGATION
- Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation
- (2012) N Giuliani et al. LEUKEMIA
- Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease
- (2011) S. D'Souza et al. BLOOD
- Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy
- (2011) Evangelos Terpos et al. INTERNATIONAL JOURNAL OF CANCER
- Myeloma cells suppress osteoblasts through sclerostin secretion
- (2011) S Colucci et al. Blood Cancer Journal
- Sclerostin: Current Knowledge and Future Perspectives
- (2010) M. J. C. Moester et al. CALCIFIED TISSUE INTERNATIONAL
- CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth
- (2010) Katia Beider et al. EXPERIMENTAL HEMATOLOGY
- Receptor Activator of NF-κB (RANK) Cytoplasmic IVVY535–538Motif Plays an Essential Role in Tumor Necrosis Factor-α (TNF)-mediated Osteoclastogenesis
- (2010) Joel Jules et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The amazing osteocyte
- (2010) Lynda F Bonewald JOURNAL OF BONE AND MINERAL RESEARCH
- TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
- (2010) Kyoko Takeuchi et al. PLoS One
- A High-Affinity Fully Human Anti-IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
- (2009) M. Fulciniti et al. CLINICAL CANCER RESEARCH
- Dickkopf-1: a suitable target for the management of myeloma bone disease
- (2009) Maria Gavriatopoulou et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Pathogenesis and management of myeloma bone disease
- (2009) Dimitrios Christoulas et al. Expert Review of Hematology
- Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
- (2008) Y.-W. Qiang et al. BLOOD
- Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma
- (2008) Martin Kaiser et al. EUROPEAN JOURNAL OF HAEMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started